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Abstract
The feasibility ofmagnetic levitational bioassembly of tissue-engineered constructs from living tissue
spheroids in the presence of paramagnetic ions (i.e. Gd3+)was recently demonstrated. However, Gd3+
is relatively toxic at concentrations above 50mMnormally used to enablemagnetic levitationwith
NdFeB-permanentmagnets. Using a highmagneticfield (a 50mm-bore, 31 TBittermagnet) at the
High FieldMagnet Laboratory at RadboudUniversity inNijmegen, TheNetherlands, we performed
magnetic levitational assembly of tissue constructs from living spheroids prepared from the SW1353
chondrosarcoma cell line at 0.8mMGd3+ containing salt gadobutrol at 19 Tmagneticfield. The
parameters of the levitation process were determined on the basis of polystyrene beadswith a 170μm-
diameter. To predict the theoretical possibility of assembly, a zone of stable levitation in the horizontal
and vertical areas of cross sectionswas previously calculated. The construct from tissue spheroids
partially fused after 3 h in levitation. The analysis of viability after prolonged exposure (1 h) to strong
magneticfields (up to 30T) showed the absence of significant cytotoxicity ormorphology changes in
the tissue spheroids. A highmagnetic fieldworks as a temporal and removal support or so-called
‘scaffield’. Thus, formative biofabrication of tissue-engineered constructs from tissue spheroids in the
highmagnetic field is a promising research direction
1. Introduction
Since the early 1990s, several authors have demon-
strated the potential of levitation in air of water and
other diamagnetic substances [1, 2]. Ikezoe et al have
succeeded in levitating, in the atmosphere, a paramag-
netic water ball containing CuSO4 (they have named
this phenomena ‘magneto-Archimedes levitation’);
although before this it was claimed that it should be
impossible to levitate paramagnetic substances [2].
Since then, principles of magnetic levitation are being
used successfully and broadly in different areas of
technology and industries [3]. In 1997, Geim per-
formed the diamagnetic levitation of a living organism
(frog) in the air at the High FieldMagnet Laboratory at
Radboud University in Nijmegen, The Netherlands,
which was a breakthrough in the area of magnetic
levitation [4]. In cell biology, as cells or tissue
spheroids (cell aggregates) are considered to be
diamagnetic, it has been proposed that their levitation
could be achieved by using a paramagnetic medium.
The most commonly used paramagnetic agents are
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gadolinium (III) chelates. This approach implies the
creation of a 3Dmagnetic trap for diamagnetic objects
in an aqueous solution of paramagnetic ions. Winkle-
man et al demonstrated trapping of polystyrene
spheres and of various types of living cells: the mouse
fibroblast cell line NIH-3T3, yeast (Saccharomyces
cerevisiae), and algae (Chlamydomonas reinhardtii)
using permanent magnets in the 40mMparamagnetic
gadolinium salt solution [5]. After studies of White-
sides’s group [6] and a series of publications from
Demirci’s group (both from Harvard University)
[7–10] several research teams around the world also
demonstrated that amagnetic levitational bioassembly
using a paramagnetic medium is technologically
feasible [11, 12]. It is worth mentioning that this
approach avoids the use of ‘labels’ of any type, namely
magnetic nanoparticles which are cytotoxic and are
proved to accumulate in human organisms after
implantation of tissue-engineered constructs contain-
ing nanoparticles [13–15].
Gadolinium(III) chelates are broadly used as con-
trast agents which are approved by the FDA for appli-
cation in clinical imaging, such as MRI [16]. For our
experiments we selected an FDA-approved
Gd3+-agent with known lowest possible toxicity—
gadobutrol (trade name ‘Gadovist’). However, the
high concentrations of Gd3+ can be potentially toxic
for cells and tissue spheroids, and a certain risk exists
for osmotic pressure imbalance due to excessive use of
ions in a paramagnetic medium. This undesirable
toxicity of gadolinium represents the main challenge
in further development of this direction.We are facing
an obvious dilemma—a high concentration of gadoli-
nium enables magnetic levitation but is relatively
toxic, whereas a low non-toxic concentration of gado-
linium does not allowmagnetic levitation with perma-
nent magnets. In such a situation, some researchers
used a low concentration of gadolinium to show
absence of toxicity, and then a higher concentration of
gadolinium to enable magnetic levitation [17]. There
are three potential strategies to resolve this dilemma:
(i) develop a non-toxic gadolinium salt; (ii) perform
magnetic levitation at a low concentration of gadoli-
nium under conditions of microgravity in Space; and
(iii) perform levitation at a low concentration of gado-
linium using a high magnetic field. There is no doubt
that the already ongoing systematic exploration of all
these three alternative strategies will eventually
advance the emerging and promising fields of magn-
etic levitational bioassembly and biofabrication. At
least, theoretically, it is possible to develop gadolinium
salts with low toxicity using chelation.Magnetic levita-
tional bioassembly experiments under microgravity
conditions have already been successfully performed
on the Russian segments of The International Space
Station in December 2018, and the results will soon be
analyzed and published. Thus, the first two strategies
are already under consideration. Now, we have also
focused on the realization of the third strategy—a
magnetic levitational bioassembly of tissue constructs
in a highmagnetic field.
Here, we report a first time successful magnetic
levitation bioassembly of 3D tissue constructs from
tissue spheroids fabricated from the SW1353 chon-
drosarcoma cell line at 100 times lower, non-toxic
concentration of a paramagnetic medium (aqueous
gadolinium salt solution) in a high magnetic field. We
show the absence of any toxic effects of either the high
magnetic field or the low concentration of gadolinium
on the viability of the cells and tissue constructs. Our
data demonstrate that magnetic levitational bioassem-
bly at a non-toxic concentration of gadolinium is tech-
nologically feasible. Moreover, our experimental
results confirmed the validity of proposals to use a
magnetic levitational bioassembly in a high magnetic
field as a cost-effective alternative to microgravity
research at The International Space Station [18–20].
We are convinced that the described methodological
approach can be further used for systematic studies of
the biological effects of microgravity on living objects
at highmagnetic fields on Earth.
2.Materials andmethods
2.1. Cell culture
The human chondrosarcoma cell line SW1353 was
purchased from the American Type Culture Collec-
tion (ATCC) (Cat. # HTB-94) and cultured in
DMEM/F12 medium with 10% fetal bovine serum
(FBS) in humidified atmosphere 5% CO2 at 37 °C.
Cells were routinely split at 85%–95% confluence
using mild enzymatic dissociation with a 0.25%
trypsin/0.53 mM EDTA solution (all reagents from
Gibco, USA).
2.2. Fabrication of tissue spheroids
Tissue spheroids were prepared using 81-well Micro-
Tissues 3D Petri dish micromolds (Sigma-Aldrich,
USA) according to the manufacturer’s protocol.
Briefly, 190 μl of SW1353 cell suspension with
concentration 3.4×106 cells per ml was placed into
each agarosemold, incubated for 1 h and then covered
with complete growth media. The resultant tissue
spheroids consisted of 8×103 cells.
2.3. Assessment of tissue spheroid viability
The viability of tissue spheroids in the presence of
paramagnetic gadobutrol (‘Gadovist’, Bayer Pharma
AG, Germany) was assessed using the CellTiter-Glo
3D kit (Promega, USA). Thus, four-day-old spheroids
were placed in 0, 0.8, 50 and 100 mM gadobutrol for
24 h. The reagent was added for 30 min, and then
luminescence was recorded using a VICTOR X3
multilabel plate reader (Perkin Elmer, USA). The
influence of a magnetic field with 19 T intensity in the
presence of an effective gadobutrol concentration (0.8
mM) on cell viability was analyzed using the Live/
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Dead Cell Double Staining Kit (Sigma-Aldrich, USA).
After the exposure in an experimental setup, the
spheroids were incubated with calcein AM and
propidium iodide at 37 °C for 1 h. After washing with
PBS, the spheroids were imaged by fluorescent micro-
scopy (Nikon Eclipse Ti-E, Japan).
2.4. Spheroid fusion assay
A spheroid fusion assay was performed using ultra-
low-adhesive spheroid microplates (Corning, USA)
(Corning, cat.# 4520). Pairs of tissue spheroids were
placed in contact in the presence of 0, 0.8 and 100mM
gadobutrol concentrations and incubated forfive days.
Bright-field images of spheroid doublets were
obtained at the time points 0, 1, 2, 3, 4, 6, 8, 12 and 24
h. Contact intersphere angles were measured using
Image J 1.48v software (NIH, Bethesda,MD,USA) and
plotted as a function of time using GraphPad Prism
software (GraphPad Software, Inc., La Jolla, CA).
2.5.Histology and electronmicroscopy
Samples were fixed in PBS-buffered 4%paraformalde-
hyde solution, then put in melted 2% agarose gel and
finally embedded in paraffin (Merck, Germany). After
dewaxing, serial sections with a thickness of 4μmwere
cut and routinely stained with hematoxylin-eosin
(Sigma-Aldrich, Germany). For transmission electron
microscopy (TEM) examination samples were fixed
with 2.5% glutaraldehyde in 0.1 M cacodylate buffer,
and post-fixedwith 1%osmium tetroxide in the buffer
containing 1.5% potassium ferricyanide. Then, the
samples were dehydrated in ethanol, and embedded in
the Epon resin. Ultrathin sections were obtained using
a Leica Ultracut UCT ultramicrotome and mounting
on Formvar-coated copper grids. The sections were
stained with 2% uranyl acetate in water and lead
citrate. The sections were observed in a Tecnai T12
electron microscope equipped with an Eagle 4k×4k
CCD camera (Thermo Fisher Scientific, The
Netherlands).
2.6.Magnetic experimental setup
To create a magnetic field, a 50 mm-bore, 31 Tesla
Bitter magnet was used (figures 1(a), (b)). To ensure
the temperature regime of 37 °C, a water thermostat
was connected to the working area of the magnet. To
place the cuvette with thematerial inside themagnet, a
custom-designed holder was used (figure 1(c)), which
fixed the cuvette at a certain height and used a mirrors
and lenses system to allow the observation of the
levitation and assembly process. LEDs were fixed to
the holder to illuminate the working area. A glass flask
with a plastic screw cap was used as a cuvette and filled
with culture medium containing polystyrene beads or
tissue spheroids with different concentrations of the
gadobutrol. A camera was used for registration of the
assembly process.
2.7.Molecular dynamics simulation of the
polystyrene beads and tissue spheroids in the
magneticfield of the Bittermagnet
The molecular dynamics (MD) modeling was carried
out as described previously [11, 21–23]. We assumed
that all particles in MD calculations were spherical,
with the same size and mass mp. For modeling
dynamics of the diamagnetic polystyrene particles in
the magnetic field of the Bitter electromagnet, we have
numerically solved the system of the Newton
equations for all the particles (1<k<N):
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where N is the number of particles for which the
simulation was performed, k is the particle serial
number in the ensemble, l is the serial numbers of
surrounding particles and rk, rl is the position of the
center of a particle k and l, respectively, = -r r r .kl k l
The first term in the right-hand part of equation (1) is
the Lennard-Jones interaction with other particles, the
second term is the interaction with the magnetic field
of the trap ∣ ∣ ( )c c= - B BFkB p s (figure 1) and
c c,p s– is the magnetic susceptibility of the particle
and solution, respectively. The third term is the force
of viscous friction against the continuum liquid which
is determined by the Stokes formula p h= - df u3 ,k k η
is the viscosity of the gadobutrol suspension, d is the
particle diameter and uk = /d dtrk is the particle
velocity relative to the stationary liquid, the fourth and
the fifth terms are a force of gravity fg and buoyancy
force fb acting on the particle. Numerical simulation
was performed for the number of particlesN=400.
The simulation was performed for polystyrene
beads and tissue spheroids with densities r = 1.0405
g cm−3 and r = 1.05 g cm−3, respectively. At the first
step, particles were distributed randomly within the
computational domain with initial zero velocity. The
computational domain corresponds to the internal
volume of the experimental cylindrical cell—
R7×25mm.
3. Results
3.1.Modelling of themagneticfield and assembly of
a construct in themagneticfield
To simulate a levitation assembly, we modelled the
magnetic field generated by a Bitter magnet
(figure 1(a)). The optimal position along the vertical
axis of the Bitter magnet was calculated from the
measured vertical field profile, following the metho-
dology described by Berry and Geim [4]. The stable
zone was determined to be 88±6mm above the field
center (figure 2).
For modeling of the assembly process, we carried
out MD simulation for the polystyrene beads. MD
simulation showed that the polystyrene beads start to
cluster after 4 min, achieving a stable assembled
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construct in 10 min (figures 3(a), (d)). The exper-
imental and simulated shapes of the assembled con-
structs have a good similarity in the final ellipsoid
volume (figures 3(b), (c)). The small difference
between experimental and simulated kinetics can be
attributed to the initial parameters of themodelling. In
simulation, the initial speed of the particles was equal
to 0, and the particles were equally distributed
throughout. In the experiment, firstly, the particles lay
at the bottom of the cuvette; secondly, it took 5 min to
get the desiredmagnetic field intensity. Because of this
wemoved the cuvette up and down to stir up the parti-
cles. As a result, the particles peaked up the initial
speed in the different directions, which contributed to
the difference between the simulation and exper-
imental results.
3.2. Assembly of constructs (aggregates) from
polystyrene beads in the highmagneticfield
The polystyrene beads were used as physical analogs of
living tissue spheroids with similar sizes and shapes.
The levitation assembly of the polystyrene bead
construct occurred at amagnetic field intensity of 22 T
in the presence of 0.5 mM gadobutrol. The assembly
occurred in 10 min (figure 5(a)). The results of the
magnetic levitation assembly of the construct from
polystyrene beads confirmed developed predictive
mathematicalmodels.
3.3. Viability of tissue spheroids
In this study we selected the human chondrosarcoma
cell line SW1353 as a reliable well-characterized
human cell source for fabrication of tissue spheroids
[24–26]. The employed fabrication method enabled
the formation of tissue spheroids with regular sizes
and shapes, which is essential for the standardization
ofmagnetic levitation assembly experiments, as well as
for the estimation of the possible toxicity of a high
magnetic field and paramagnetic medium
(figure 4(a)). The spheroid fusion assay showed that at
a low concentration of gadolinium salt (0.8 mM
gadobutrol) tissue spheroids can fuse, which
Figure 1.Themagnetic installation. (А)A scheme ofmagnetic installation of a 50mm-bore, 31 TBittermagnet; (B) a photograph of
the Bittermagnet; (C) a cuvette with tissue spheroids inmedium supplementedwith gadobutrol, placed in custom-designed
mounting.
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confirmed their viability and capacity to migrate from
the surface during the tissue fusion process
(figure 4(b)). As shown in figure 4(b), the intersphere
angle increased as a function of time, and in 20 h, after
the beginning of incubation, the intersphere angle
increased up to 179° indicating complete spheroid
fusion.
To quantitatively evaluate the toxicity of gadobu-
trol on SW1353 tissue spheroids, we used a CellTiter-
Glo 3D kit. At a low concentration of gadobutrol (0.8
mM) the tissue spheroids were 100% viable, whereas
at a high concentration of gadobutrol (100mM) viabi-
lity decreased down to 70% in 24 h (figure 4(c)). Hav-
ing taken into account the fact that the complete
spheroid fusion takes at least 20 h, such cytotoxicity is
crucial.
We also performed TEM studies of cells and tissue
spheroids incubated at a high concentration of gado-
butrol (50 mM). As shown in figure 4(d), in the
absence of gadobutrol (control) no ultrastructural
changes were observed. TEM showed that 50 mM
gadobutrol caused cell injury (figure 4(e)) accom-
panied by intracellular dystrophy, which correlated
with the previous reports [3, 27, 28]. The toxic effect of
gadolinium(III)-based gadobutrol at high concentra-
tion (>50 mM) on cell ultrastructure usually includes:
(i)margination of nuclear chromatin (figure 4(f)), (ii)
swelling and reduction in the number of cristae in
mitochondria (figure 4(g)), (iii) enlargement of the
endoplasmic reticulum (figure 4(h)), as well as (iv) for-
mation of phagosomes (figure 4(i)) and (v) severe
vacuolization of the cytoplasm (figure 4(j)). It is worth
mentioning that this set of ultrastructural changes is
irreversible as it does not improve after 1–2 day incu-
bation in gadolinium-free medium. In the case of a
low concentration of gadolinium the ultrastructure
remains intact. Taken together the reported observa-
tions strongly indicate cell and tissue viability and the
absence of ultrastructural changes in cells of tissue
spheroids after their incubation with low doses of
gadobutrol.
3.4. Assembly of tissue-engineered construct from
tissue spheroids in a highmagneticfield
The assembly during levitation of tissue spheroids was
carried out at a magnetic field intensity of 19 T and a
concentration of 0.8 mM gadobutrol. In contrast to
polystyrene beads (figure 5(a)), the process of tissue
spheroid assembly (figure 5(b)) took 40 min, which
results from some differences in magnetic properties
between polystyrene beads and tissue spheroids and
the difference in intensities of the magnetic field used.
Figure 2.The characteristics of themagnetic field in the Bittermagnet. The calculation of a stable levitation zone, where z—the
coordinate on the vertical axis of amagnet from its top field profile is the dependence ofmagnetic strength intensity B on coordinate z.
D1 andD2 are discriminants of vertical and horizontal stability conditions (the arrows show the zone of vertical and horizontal
convergence, whose coordinate is equal to∼383±6mm from the top of themagnet or 88±6mm from its center).
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After the spheroids clustered together, the construct
was kept under the same levitation conditions for 3 h
to ensure fusion of tissue spheroids into a single
construct (figure 5(c)). The histology of the construct
fragment (figure 5(c), insert circle) demonstrates
intact morphology of the tissue spheroids. A series of
experiments were performed to show the interdepen-
dence between the paramagnetic salt concentration in
the medium, the tissue spheroids’ or beads’ properties
and the intensity of the magnetic field to maintain a
stable levitation for construct formation. The results
show that these parameters can be turned, while the
concentration of gadobutrol and the magnetic field
applied are directly related despite some small varia-
tions between the polystyrene beads’ and tissue
spheroids’ levitation characteristics (figure 5(d)). The
beads or spheroids are initially located in the bottom
of the cuvette when no magnetic field is applied
independently of the gadobutrol used in this study.
Upon screening of different magnetic fields and
gadobutrol concentrations it was possible to define
trend curves that were used to define the threshold
values to achieve a levitation state. Figure 5(d) shows
the threshold values required to promote polystyrene
bead or tissue spheroid levitation, where areas above
the curve mean that objects levitate in the vertical
direction upwards; the area below the curve means
that the objects are not levitating. These data demon-
strate that magnetic levitation of both polystyrene
beads and tissue spheroids is possible in a high
magnetic field at a low non-toxic concentration of
gadolinium salt (figure 5(d)).
We performed a Live/Dead assay for tissue spher-
oids after incubation in 0.8mMgadobutrol in the high
magnetic field (19 T). In the low concentration of
gadobutrol the high magnetic field provides levitation
of tissue spheroids without affecting their viability
(figure 5(e)). It was also confirmed by TEM, which did
not identify strong ultrastructural changes
(figure 5(f)). Taken together, these data strongly indi-
cate the maintenance of the tissue spheroids’ viability
exposed to the combination of a high magnetic field
(19 T) and a low concentration of gadobutrol (0.8
mM). Thus, our theoretical and experimental data
demonstrate, for the first time, that magnetic levita-
tion assembly based on tissue spheroid fusion at a
non-toxic concentration of gadolinium in a high
Figure 3.MDsimulation of the construct assembly in themagnetic trap for polystyrene beads. The number of beads is 400, and the
diameter is 175μm. (a)Assembly stages in theMDmodelling (side view); (b) the appearance of constructs after experimental
assembly; (c) the appearance of constructs aftermodelling assembly (measurement units along the axis—mm, vector g oriented in the
vertical downdirection); (d) assembly stages in theMDmodelling (bottom view).
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magnetic field is technologically feasible and can be
implemented.
4.Discussion
We have performed, for the first time, the magnetic
levitational bioassembly of a viable 3D tissue construct
in a high magnetic field. Magnetic levitation was
achieved at a very low concentration of paramagnetic
medium (Gd3+-chelate gadobutrol), almost 100 times
lower than the concentration which was used in
previously reported studies [17, 29]. Although gadoli-
nium-based chelates are approved by the FDA as
contrast agents for application in MRI [16], there is
evidence that gadolinium chelates accumulate in
human organisms (predominantly in the kidney,
which leads to undesirable side effects—kidney
damage in the form of so-called ‘nephrogenic systemic
fibrosis’ [30, 31]), thus causing toxic effects. In the case
of living cells, and especially for tissue spheroids, it is
necessary to reduce the amount of toxic paramagnetic
gadolinium chelates. Application of a high magnetic
field (19 T) allowed us to reduce cytotoxic effects due
to the use of lower concentrations of gadolinium salts
(0.8 mM) required for magnetic levitation. We took
advantage of the existing European High Magnet
Laboratory in Nijmegen and performed our experi-
ments. It is noteworthy that the results of magnetic
levitational assembly of polystyrene beads and tissue
spheroids were in agreement with developed mathe-
matical models that demonstrates their strong pre-
dictive power.
This is the first report that investigated the tissue
spheroid’s viability in an ultra-high magnetic field.
There are only a few reported studies that have investi-
gated animal or human cells at strong magnetic fields
Figure 4.The toxicity of gadobutrol and themagnetic field. (a)The fabrication of spheroids using non-adhesive agarosemolds; (b) the
fusion of spheroids in the presence of 0.8mMgadobutrol (top) and the time-curve of intersphere angles during the fusion (bottom);
(c) the viability of spheroids at different concentrations of gadobutrol (0, 0.8, 50, 100mM); (d) a TEM image of tissue spheroids in the
absence of gadobutrol (control); (e) a TEM image of tissue spheroids in the presence of 50mMgadobutrol (sample); (f)–(j)
ultrastructural changes in cells within tissue spheroids caused by a high concentration of gadobutrol (50mM): (f)margination of
nuclear chromatin; (g) swelling and reduction of the number of cristae inmitochondria; (h) enlargement of the endoplasmic
reticulum aswell as; (i) formation of phagosomes; (j) severe vacuolization of the cytoplasm.
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(>10 T). Nakahara et al and Zhao et al showed that 10
T or 13 T static magnetic fields did not influence the
viability of human-hamster (AL) hybrid cells, Chinese
hamster ovary (CHO) cells or human primary skin
fibroblasts (AG1522) [32, 33]. Valiron et al used 17 T,
and they did not observe strong killing effects on cells
but they found that 17 T had an obvious effect on the
cytoskeleton of the interphase [34]. Zhang et al used 27
T, the highest static magnetic field strength applied on
cells so far, and their results were in accordance with
the data of Valiron’s group [35]. To investigate the via-
bility of tissue spheroids levitated in a high magnetic
field (19 T) at a low concentration of gadolinium salts,
we performed three different viability tests and
revealed the experimental setup. To investigate more
precisely the cell alterations after exposure to a high
magnetic field, the proteomics and genomics studies
of cells and tissue spheroids should be carried out in
future investigations.
We did not apply any synthetic or natural scaffolds
or even magnetic nanoparticles in this study and,
therefore, called this technology both ‘scaffold-free’
and ‘label-free’. In our experiments the employed high
magnetic field served as some sort of ‘temporal and
removable support’, which fits very well to the classic
definition of a scaffold in tissue engineering [36]. To
escape potential confusion, we previously suggested
use of the new designation ‘scaffield’ for defining tem-
poral and removable support provided by any type of
physical fields, including the high magnetic field
employed in this study [11]. We also suggested defin-
ing this type of rapid biofabrication based on using
scaffield ‘formative biofabrication’, which is
Figure 5.The construct assembly under highmagneticfield levitation. (a)The polystyrene beads assembling at 0.5mMgadobutrol
and amagneticfield intensity of 22Т; (b) tissue spheroids assembling until a stable construct was obtained at 0.8mMgadobutrol and a
magnetic field intensity of 19Т; (c) the construct assembled after 3 h at 19Т (insert circle shows a histological section of the construct);
(d) the curves of levitation conditions depending on the gadobutrol concentration andmagneticfield intensity applied for tissue
spheroids (red curve) and polystyrene beads (blue curve); (e) the Live/Dead assay for tissue spheroids after 1 h of exposure to 19 T
magnetic field at 0.8mMgadobutrol (scale bar 100μm); (f) a TEM image of a tissue spheroid after 1 h of exposure to 19Tmagnetic
field at 0.8mMgadobutrol.
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conceptually different from conventional ‘layer-by-
layer’ additive biofabrication and 3Dbioprinting.
It is worthmentioning that our results support the
previous proposals on the use of magnetic levitation
on the Earth for simulation of microgravity as a cost-
effective alternative tomuchmore expensive studies of
the microgravity effects on the living objects in Space,
i.e. on the International Space Station.
5. Conclusion
The minimum concentration of gadobutrol (0.8 mM)
enabling magnetic levitation assembly was identified.
The Live/Dead assay revealed minimal cytotoxicity of
the magnetic field with intensity up to 30 T for tissue
spheroids after 1 h of exposure. The model construct
frompolystyrene beads (the physical analogue of tissue
spheroids) was successfully assembled at a magnetic
field with an intensity of 22 T in 10 min of exposure.
Constructs from living tissue spheroids (human chon-
drosarcoma SW1353 cell line) were assembled at 19 T
and fusion was achieved in 3 h. The scaffold-free and
label-free formative biofabrication of tissue-engi-
neered constructs from tissue spheroids based on
magnetic levitational assembly in the high magnetic
field is a technologically feasible and very promising
substitute for the Space infrastructure that might
increase the intensity and decrease the timeline of
research. Thus, our study supports proposals to use
high magnetic levitation as a cost-effective alternative
to life science research on the effects ofmicrogravity.
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